| |
Date |
| BSD Medical Submits Grant Applications under the Qualifying Therapeutic Discovery Project Program |
July 26, 2010 |
 |
| BSD Medical Provides Information Requested by FDA for the MicroThermX Ablation System 510(k) Submission |
July 21, 2010 |
|
| BSD Medical Announces Presentation at ASCO of Duke University Clinical Study Using Hyperthermia with Chemotherapy to Treat Bladder Cancer |
July 15, 2010 |
|
| BSD Medical Reports Progress in the FDA Review of MicroThermX Ablation System 510(k) Submission |
July 12, 2010 |
|
| BSD Medical Exhibits MicroThermX® Microwave Ablation System at World Conference on Interventional Oncology |
June 23, 2010 |
|
| BSD Medical Reports Hyperthermia Use with Particle Therapy Highlighted at German Society of Radiation Oncology Meeting |
June 17, 2010 |
|
| BSD Medical Reports Presentation of Cochrane Review on the use of Hyperthermia in Cervical Cancer Treatment at ESHO 2010 Meeting |
June 8, 2010 |
|
| BSD Medical Reports Impressive Results from Clinical Study on Pancreatic Cancer Presented at ESHO 2010 Meeting |
June 2, 2010 |
|
| BSD Medical Reports Press Release Issued by The Lancet Oncology on Significant Sarcoma Study using BSD-2000 Hyperthermia System |
May 4, 2010 |
|
| BSD Medical Announces Registered Direct Offering of Common Stock and Warrants in Aggregate Amount of $2.5 Million |
May 3, 2010 |
|
| BSD Medical Reports Study Results Published in Lancet Oncology Demonstrate Improved Survival for Sarcoma Cancer Patients Treated with Hyperthermia |
April 29, 2010 |
|
| Clinical Study using the BSD-2000 Hyperthermia System Combined with Chemotherapy to Treat Pediatric Tumors Shows Promise |
April 22, 2010 |
|
| TV News Coverage Reports on Duke University Hyperthermia Research Using BSD Medical’s Equipment |
March 25, 2010 |
|
| BSD Medical Files FDA 510(k) Submission to Market Phase II MicroThermX Ablation System |
March 23, 2010 |
|
| BSD Medical Retains Financial Profiles for Investor Relations |
March 3, 2010 |
|
| BSD Medical Reports Publication of Chinese Study Using the BSD-2000 Hyperthermia System to Treat Lung Cancer |
February 23, 2010 |
|
| BSD Medical Announces First Swiss Installation of the BSD-2000/3D Hyperthermia System at Kantonsspital Aarau |
February 18, 2010 |
|
| BSD Medical Announces Registered Direct Offering of Common Stock and Warrants in Aggregate Amount of $2 Million |
February 11, 2010 |
|
| BSD Medical Reports Formation of Corporate Governance and Nominating Committee |
February 11, 2010 |
|
| BSD Medical Reports Initiation of a Phase III Study on Pancreatic Cancer Using the BSD-2000 Hyperthermia System in Combination with Chemotherapy |
February 9, 2010 |
|
| BSD Medical Reports Publication of Hyperthermia Article by Journal of the National Cancer Institute |
February 2, 2010 |
|
| BSD Medical Sells Two BSD-2000 Hyperthermia Systems to Chinese Distributor |
January 26, 2010 |
|
| BSD Medical Names Todd Turnlund as Vice President of Engineering |
January 19, 2010 |
|
| BSD Medical Reports German Society of Radiation Oncology Press Release: Addition of Hyperthermia to Standard Therapy is Effective for Treatment of Bladder Cancer |
December 14, 2009 |
|
| BSD Medical Corporation Reports Continuation of FDA Review of BSD-2000 Hyperthermia System |
November 18, 2009 |
|
| BSD Medical Reports Hyperthermia Therapy Contributes to Improved Survival Rate for Bladder Cancer Patients |
October 30, 2009 |
|
| BSD Medical Corporation Sells Hyperthermia System to University of California, San Francisco Medical Center |
September 29, 2009 |
|
| BSD Medical Corporation Files $50 Million Shelf Registration |
September 24, 2009 |
|
| BSD Medical Reports News Briefing at Europe’s Largest Cancer Congress: Hyperthermia and Chemotherapy Treatment Prolongs Survival of Sarcoma Cancer Patients |
September 22, 2009 |
|
| BSD Medical Corporation Reports FDA Review of BSD-2000 Hyperthermia System Continues |
September 18, 2009 |
|
| BSD Medical Hyperthermia System Integrated with GE Healthcare MR System at Duke University School of Medicine |
July 31, 2009 |
|
